Skip to main content

INMUNIZACION EN BACTERIAS: ADAPTACION DEL SISTEMA CRISPR-CAS I-E DE ESCHERICHIA COLI Y SALMONELLA ENTERICA.

BIO2014-53029-P

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D (Excelencia / Generación de Conocimiento)
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE ALICANTE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Next-generation precision antimicrobials: towards personalized treatment of infectious diseases

  • Fuente-Nunez, Cesar de la
  • Torres, Marcelo D.T.
  • Mojica, Francisco J.M.
  • Lu, Timothy K.
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
Antibiotics started to be used almost 90 years ago to eradicate life-threatening infections. The urgency of the problem required rapid, broad-spectrum elimination of infectious agents. Since their initial discovery, these antimicrobials have saved millions of lives. However, they are not exempt from side effects, which include the indiscriminate disruption of the beneficial microbiota. Recent technological advances have enabled the development of antimicrobials that can selectively target a gene, a cellular process, or a microbe of choice. These strategies bring us a step closer to developing personalized therapies that exclusively remove disease-causing infectious agents. Here, we advocate the preservation of our beneficial microbes and provide an overview of promising alternatives to broad-spectrum antimicrobials. Specifically, we emphasize nucleic acid and peptide-based systems as a foundation for next-generation alternatives to antibiotics that do not challenge our microbiota and may help to mitigate the spread of resistance.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

The CRISPR conundrum: evolve and maybe die, or survive and risk stagnation

  • García-Martínez, Jesús
  • Maldonado, Rafael
  • Guzmán, Noemí M.
  • Mojica, Francisco J.M.
  • García-Martínez, Jesús|||/items/443272e9-7815-4169-b0db-0507805a8e1d
  • Guzmán, Noemí M.|||/items/499e7143-a3fa-4486-8e83-28ba178c287f
  • Maldonado, Rafael|||/items/37bf5b23-bc7c-4ceb-b309-26d49626d424
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
CRISPR-Cas represents a prokaryotic defense mechanism against invading genetic elements. Although there is a diversity of CRISPR-Cas systems, they all share similar, essential traits. In general, a CRISPR-Cas system consists of one or more groups of DNA repeats named CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), regularly separated by unique sequences referred to as spacers, and a set of functionally associated cas (CRISPR associated) genes typically located next to one of the repeat arrays. The origin of spacers is in many cases unknown but, when ascertained, they usually match foreign genetic molecules. The proteins encoded by some of the cas genes are in charge of the incorporation of new spacers upon entry of a genetic element. Other Cas proteins participate in generating CRISPR-spacer RNAs and perform the task of destroying nucleic acid molecules carrying sequences similar to the spacer. In this way, CRISPR-Cas provides protection against genetic intruders that could substantially affect the cell viability, thus acting as an adaptive immune system. However, this defensive action also hampers the acquisition of potentially beneficial, horizontally transferred genes, undermining evolution. Here we cover how the model bacterium Escherichia coli deals with CRISPR-Cas to tackle this major dilemma, evolution versus survival.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR–Cas I-F systems

  • Almendros, Cristóbal
  • Guzmán, Noemí M.
  • García-Martínez, Jesús
  • Mojica, Francisco J.M.
  • García-Martínez, Jesús|||/items/443272e9-7815-4169-b0db-0507805a8e1d
  • Guzmán, Noemí M.|||/items/499e7143-a3fa-4486-8e83-28ba178c287f
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
Archaea and bacteria harbour clustered regularly interspaced short palindromic repeats (CRISPR) loci. These arrays encode RNA molecules (crRNA), each containing a sequence of a single repeat–intervening spacer. The crRNAs guide CRISPR-associated (Cas) proteins to cleave nucleic acids complementary to the crRNA spacer, thus interfering with targeted foreign elements. Notably, pre-existing spacers may trigger the acquisition of new spacers from the target molecule by means of a primed adaptation mechanism. Here, we show that naturally occurring orphan CRISPR arrays that contain spacers matching sequences of the cognate (absent) cas genes are able to elicit both primed adaptation and direct interference against genetic elements carrying those genes. Our findings show the existence of an anti-cas mechanism that prevents the transfer of a fully equipped CRISPR–Cas system. Hence, they suggest that CRISPR immunity may be undesired by particular prokaryotes, potentially because they could limit possibilities for gaining favourable sequences by lateral transfer.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants

  • Makarova, Kira S.
  • Wolf, Yuri I.
  • Iranzo, Jaime
  • Shmakov, Sergey A.
  • Alkhnbashi, Omer S.
  • Brouns, Stan J.J.
  • Charpentier, Emmanuelle
  • Cheng, David
  • Haft, Daniel H.
  • Horvath, Philippe
  • Moineau, Sylvain
  • Mojica, Francisco J.M.
  • Scott, David
  • Shah, Shiraz A.
  • Siksnys, Virginijus
  • Terns, Michael P.
  • Venclovas, Česlovas
  • White, Malcolm F.
  • Yakunin, Alexander F.
  • Yan, Winston
  • Zhang, Feng
  • Garrett, Roger A.
  • Backofen, Rolf
  • Oost, John van der
  • Barrangou, Rodolphe
  • Koonin, Eugene V.
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
The number and diversity of known CRISPR–Cas systems have substantially increased in recent years. Here, we provide an updated evolutionary classification of CRISPR–Cas systems and cas genes, with an emphasis on the major developments that have occurred since the publication of the latest classification, in 2015. The new classification includes 2 classes, 6 types and 33 subtypes, compared with 5 types and 16 subtypes in 2015. A key development is the ongoing discovery of multiple, novel class 2 CRISPR–Cas systems, which now include 3 types and 17 subtypes. A second major novelty is the discovery of numerous derived CRISPR–Cas variants, often associated with mobile genetic elements that lack the nucleases required for interference. Some of these variants are involved in RNA-guided transposition, whereas others are predicted to perform functions distinct from adaptive immunity that remain to be characterized experimentally. The third highlight is the discovery of numerous families of ancillary CRISPR-linked genes, often implicated in signal transduction. Together, these findings substantially clarify the functional diversity and evolutionary history of CRISPR–Cas.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

An updated evolutionary classification of CRISPR–Cas systems

  • Makarova, Kira S.
  • Wolf, Yuri I.
  • Alkhnbashi, Omer S.
  • Costa, Fabrizio
  • Shah, Shiraz A.
  • Saunders, Sita J.
  • Barrangou, Rodolphe
  • Brouns, Stan J.J.
  • Charpentier, Emmanuelle
  • Haft, Daniel H.
  • Horvath, Philippe
  • Moineau, Sylvain
  • Mojica, Francisco J.M.
  • Terns, Rebecca M.
  • Terns, Michael P.
  • White, Malcolm F.
  • Yakunin, Alexander F.
  • Garrett, Roger A.
  • Oost, John van der
  • Backofen, Rolf
  • Koonin, Eugene V.
  • Mojica, Francisco J.M.|||/items/f14a8472-85f4-48a8-bb8d-3ee259963240
The evolution of CRISPR–cas loci, which encode adaptive immune systems in archaea and bacteria, involves rapid changes, in particular numerous rearrangements of the locus architecture and horizontal transfer of complete loci or individual modules. These dynamics complicate straightforward phylogenetic classification, but here we present an approach combining the analysis of signature protein families and features of the architecture of cas loci that unambiguously partitions most CRISPR–cas loci into distinct classes, types and subtypes. The new classification retains the overall structure of the previous version but is expanded to now encompass two classes, five types and 16 subtypes. The relative stability of the classification suggests that the most prevalent variants of CRISPR–Cas systems are already known. However, the existence of rare, currently unclassifiable variants implies that additional types and subtypes remain to be characterized.